Home
Audentes Therapeutics

Audentes Therapeutics Market Share Analysis for June 2026

astellas pharma inc., based in tokyo, japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

Health > Biotechnology and Pharmaceuticals

Domainaudentestx.com

Year Founded--

Employees201 - 500

Annual Revenue--

Audentes Therapeutics

Audentes Therapeutics (including company regionals)

audentestx.com

See more website traffic and engagement information

Audentes Therapeutics Revenue up to June 2026 is --

revenue generated by Audentes Therapeutics top domains

Audentes Therapeutics top domains revenue over 3 years

Revenue for Audentes Therapeutics top domains

audentestx.com--

See more with Sales Intelligence

Total visits to Audentes Therapeutics's top domains

Understand Audentes Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Audentes Therapeutics's top domains

Analyze Audentes Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Audentes Therapeutics's top domains

See how Audentes Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Audentes Therapeutics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

alixarx.comCompany NameAlixaRxEmployees501 - 1000HQUnited States, Texas, PlanoAnnual revenue$50M - $75MTotal visits4.8KHealth > Pharmacy

Top technologies used by Audentes Therapeutics

These are the website technologies, by industry, used by Audentes Therapeutics top domains

Payment & Currencies (10)

Cart Functionality

Widget (4)

Twemoji

Audio Video Media (3)

YouTube

eCommerce (3)

USPS

More Technologies

11

See all

News & Signals from Audentes Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVera Switek leaves Audentes Therapeutics, Inc. as Senior Director of Talent Acquisition.Vera Switek, Vice President of Talent: Vera Switek joins Scribe from Audentes Therapeutics, where she served as Senior Director of Talent Acquisition.

NewsAudentes Therapeutics, Inc. is developing gene therapy products on Oct 1st '15.Audentes Therapeutics made an announcement in October 2015 that company is giving $65 Million in series C financing to develop and commercialize gene therapy products to treat patients suffering from rare and serious illnesses.

NewsAudentes Therapeutics, Inc. launched international gene therapy clinical trial for myotubular myopathy on Jan 1st '17.In 2017 Audentes launched the first international gene therapy clinical trial for myotubular myopathy.